Opportunistic fungal infections are a leading cause of death among immune-compromised patients, and there is a pressing need to develop new antifungal therapeutic agents because of toxicity and resistance to the antifungal drugs currently in use. Although C-type lectin receptor-and Toll-like receptor-induced signaling pathways are key activators of host antifungal immunity, little is known about the mechanisms that negatively regulate host immune responses to a fungal infection. Here we found that JNK1 activation suppresses antifungal immunity in mice. We showed that JNK1-deficient mice had a significantly higher survival rate than wild-type control mice in response to Candida albicans infection, and the expression of JNK1 in hematopoietic innate immune cells was critical for this effect. JNK1 deficiency leads to significantly higher induction of CD23, a novel C-type lectin receptor, through NFATc1-mediated regulation of the CD23 gene promoter. Blocking either CD23 upregulation or CD23-dependent nitric oxide production eliminated the enhanced antifungal response found in JNK1-deficient mice. Notably, JNK inhibitors exerted potent antifungal therapeutic effects in both mouse and human cells infected with C. albicans, indicating that JNK1 may be a therapeutic target for treating fungal infection.
Every year, invasive fungal infections kill approximately one and a half million people worldwide 1, 2 . C. albicans is the most frequent fungal species isolated from infected patients 3 . Increasing numbers of immunocompromised individuals, including individuals with HIV, recipients of organ transplants and patients with cancer treated with chemotherapy, together with limited numbers of antifungal drugs for use in clinical application and drug resistance are the main reasons for the high morbidity and mortality associated with disseminated candidiasis 1, 4 . Therefore, understanding how the host immune system fights fungal infections is crucial for the development of novel immune-response-based therapies 2, 5 .
Pattern recognition receptors-including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), Nod-like receptors (NLRs) and RIG-I-like receptors (RLRs)-initiate the host immune response against invading pathogens 6 . Previous studies indicate that CLRs play critical roles in recognizing fungal surface components, leading to induction of the host antifungal immune responses [5] [6] [7] [8] . CLRs, including dectin-1, dectin-2 and dectin-3 (also named MCL), recognize the various carbohydrate glycoprotein components of the fungal cell wall, such as β-glucan or α-mannan, which trigger downstream signaling cascades that are essential for inducing protective immunity against fungi in the host [9] [10] [11] [12] [13] [14] . Activation of spleen tyrosine kinase (Syk) through CLRs triggers CARD9-BCL10-MALT1 (CBM)-complex-dependent NF-κB signaling in macrophages or dendritic cells (DCs), which then leads to the release of proinflammatory cytokines-including tumor necrosis factor (TNF)-α, IL-6 and IL-17, among others 15, 16 . Phagocytosis, reactive oxygen species (ROS) production, neutrophil recruitment and inflammasome activation have been shown to play critical roles in the fungal killing process [6] [7] [8] . Recently, three groups, including ours, have reported that activated CLRs are rapidly targeted for lysosomemediated degradation in response to fungal infection [17] [18] [19] .
c-Jun N-terminal kinases (JNKs) play important roles in T cell activation and T helper cell differentiation, cell apoptosis, obesity, insulin resistance and tumorigenesis [20] [21] [22] [23] . Many efforts have identified various ATP-competitive or ATP-noncompetitive JNK inhibitors 24, 25 . Although studies have shown that JNK can be activated by various pattern recognition receptors 22 , the functional roles of JNK in innate immune responses have not been well characterized. In particular, the role of JNK activation in host antifungal responses has not been studied. Here we report that JNK1 negatively regulates the host antifungal innate immune response through suppression of CD23 expression and may serve as a therapeutic target in fungal infection.
RESULTS

JNK1 negatively regulates host antifungal innate immune responses in vivo
To investigate the role of JNK in response to fungal infection, bone marrow-derived macrophages (BMDMs) were stimulated with the yeast or hyphal form of C. albicans and the fungal cell wall component zymosan or α-mannan. Each stimuli can effectively induce JNK1 and JNK2 (JNK1/2) phosphorylation (Fig. 1a) . To further characterize the role of JNK function in the host immune response to fungal infection, we intravenously infected JNK1 knockout (KO), JNK2 KO and . Insets show regions of fungal inflammation, fungal growth and neutrophil infiltration, respectively, and are higher-magnification views of the boxed areas. Representative images of at least three replicates are shown. Scale bars, 500 µm (50 µm in insets). (e) The inflammatory score based on renal immune cell infiltration and tissue destruction, the fungal burden and the percentage of the area positive for Ly-6G are shown. n = 3 mice for each group, and three sections per kidney were analyzed. (f) BM cells from JNK1 KO (n = 10) and WT (n = 10) mice were intravenously injected into irradiated recipient mice separately. Seven weeks later, mice were intravenously infected with 2 × 10 5 CFU of C. albicans. Survival of these mice was monitored. WT-KO mice are JNK1 KO irradiated mice that received WT BM cells. (g) JNK1 WT/Rag1 KO (n = 7) and JNK1 KO/Rag1 KO (n = 8) mice were intravenously infected with 2 × 10 5 CFU of C. albicans per mouse. Survival of these mice was monitored. In b,f,g, the log-rank test was performed; in c, the two-tailed unpaired t-test was performed; in e, the multiple t-test was performed. n.s. (not significant), P > 0.05; *P < 0.05, **P < 0.01, ***P < 0.001. In c,e, data are shown as means ± s.e.m.
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wild-type (WT) control mice with a sub-lethal dose of C. albicans. We found that JNK1 KO mice were more resistant to fungal infection than JNK2 KO or WT mice (Fig. 1b) . Consistently, the fungal load in the kidneys of JNK1 KO mice was significantly lower than that in WT mice ( Fig.  1c and Supplementary Fig. 1a ). JNK1 KO mice also exhibited reduced renal inflammation and reduced numbers of C. albicans colony forming units (CFU) in the kidney (Fig. 1d,e and Supplementary Fig. 1b,c) . The above findings were confirmed using two different doses of fungus in JNK1 KO mice and their heterozygous littermates ( Supplementary Fig.  1d ,e). These data suggest that deficiency of JNK1, but not JNK2, in the host leads to a boost in host antifungal immunity. Myeloid lineage cells, including macrophages and DCs, are key effector cells against fungi during the first few days of fungal infection 3, 26 . JNK1 has been reported to be ubiquitously expressed in most of the cell types in the human body 22 . To investigate the cellular basis of the JNK1-related antifungal effect, we generated bone marrow (BM)-chimeric mice by reconstituting lethally irradiated WT mice with syngeneic JNK1 KO BM or JNK1 KO mice with WT BM. WT mice reconstituted with JNK1 KO hematopoietic cells showed a phenotype similar to that of mice with total JNK1 deficiency in response to C. albicans infection ( Fig. 1f and Supplementary Fig. 1f , KO-WT versus KO-KO). Hematopoietic cells comprise both innate and adaptive immune cells. To determine the contribution of JNK1 that is expressed in the adaptive immune system to the fungal infection phenotype, we generated JNK1 and Rag1 double-KO mice by crossing JNK1 KO mice with Rag1 KO mice. Notably, the phenotype of mice with JNK1 deficiency in the absence of adaptive immune cells closely resembled that of mice with whole-body JNK1 KO in response to C. albicans infection (Fig. 1g) . Together, these data indicate that JNK1 negatively regulates the antifungal innate immune response in vivo. for the indicated time. NO production in culture supernatants at the indicated time point was measured by nitrite assay kit. (f) P30A or control (pCtr) peptide (10 µg/ml) was added to C. albicans, and cells were treated for 48 h. NO production in culture supernatants was measured by nitrite assay kit. Representative data from three biological replicates are shown. For each biological replicate, BMDMs from one mouse were used. In c-f, the multiple t-test was performed. *P < 0.05, **P < 0.01, ***P < 0.001. In c-f, data are shown as means ± s.e.m.
a r t i c l e s 3 4 0 VOLUME 23 | NUMBER 3 | MARCH 2017 nature medicine JNK1 deficiency induces elevated CD23 expression and nitric oxide production in vitro Proinflammatory cytokines, such as IL-6 and TNF-α, are reported to be key factors required for the innate immune system to protect the host from fungi 5, 26 . However, we did not detect significant differences in the levels of these proinflammatory cytokines after fungal infection in JNK1 KO mice when compared with WT mice using multiplex cytokine array analysis ( Supplementary Fig. 2a ), which we confirmed in vitro using BMDMs stimulated with C. albicans ( Supplementary  Fig. 2b ). Activation of p38 and ERK was also comparable in WT and JNK1 KO cells (Supplementary Fig. 2c ). To identify gene(s) that might be responsible for resistance to fungal infection in JNK1 KO mice, we performed RNA-seq analysis on WT and JNK1 KO BMDMs after stimulation with yeast-form C. albicans ( Supplementary Fig. 3a) . Notably, we found that a novel C-type lectin gene, Fcer2a, was significantly upregulated in stimulated JNK1 KO cells when compared with WT control cells (Fig. 2a) . Fcer2a encodes the protein CD23, which was identified as the lowaffinity receptor for IgE 27 and also functions as a CLR. It is located on chromosome 19p131 and forms a gene cluster with Cd209a, which encodes DC-SIGN 28 . To validate the RNA-seq data, we analyzed the expression of a series of CLR genes by quantitative real-time PCR and found that Fcer2a was the only gene that was significantly induced in JNK1 KO BMDM cells compared with WT cells ( Supplementary  Fig. 3b ). We confirmed upregulation of CD23 protein on the cell surface upon C. albicans stimulation by flow cytometry analysis (Fig. 2b) . As CD23 is also a CLR, we examined whether it can directly recognize surface components of fungi by performing a cellular binding assay. Indeed, we found that CD23 could bind both the yeast and hyphal forms of C. albicans (Supplementary Fig. 4a ). Since the C. albicans cell wall is mainly composed of α-mannan and β-glucan, we performed atomic force microscopy (AFM) and ligand-binding assays to determine whether CD23-expressing cells and/or CD23 protein can directly bind α-mannan and β-glucan. We found that both cell-surface-expressed CD23 and purified, soluble CD23 could effectively bind to α-mannan and β-glucan (or Curdlan) in a manner similar to that of the known CLRs dectin-1 and dectin-3 ( Fig. 2c,d and Supplementary Fig. 4b ).
It has been reported that infection of human monocyte-derived macrophages with Mycobacterium avium increases membrane expression of CD23 (ref. 29) and that CD23 induces nitric oxide synthase (NOS) activity in human monocytes 30, 31 . Furthermore, CD23 and nitric oxide (NO) are involved in the killing of Leishmania and M. avium by human macrophages 29, 32, 33 . Notably, Nos2, which encodes the inducible NOS (iNOS), was highly differentially expressed between WT and JNK1 KO cells following C. albicans stimulation (Fig. 2a) . Moreover, we found that both α-mannan and β-glucan could stimulate the CD23-overexpressing monocyte cell line Raw264.7 to produce more NO (Supplementary Fig. 4c) . Notably, JNK1 KO BMDMs had approximately threefold more soluble NO in their supernatants than WT cells following C. albicans infection (Fig. 2e) ; this finding is consistent with the significant induction of Nos2 mRNA observed in JNK1 KO cells relative to WT cells (Supplementary Fig. 5a ). Furthermore, this elevated NO production in JNK1 KO cells was CD23 dependent, since JNK1 KO BMDMs secreted much less NO upon treatment with p30A (Fig. 2f) , a CD23-blocking peptide that effectively induces CD23 endocytosis from the cytoplasmic membrane, than BMDMs treated with control peptide 34 . p30A treatment efficiently decreased cell surface expression of CD23 in both WT and JNK1 KO BMDMs infected with C. albicans (Supplementary Fig. 5b) , and p30A-treated JNK1 KO BMDMs could not kill C. albicans as efficiently as JNK1 KO cells treated with a control peptide (Supplementary Fig. 5c ). Using an NO synthesis inhibitor, l-NAME, to block NO production also abolished the in vitro killing of C. albicans by JNK1 KO BMDMs ( Supplementary  Fig. 5d,e) . Together, these results show that JNK1 deficiency leads to upregulation of CD23 and higher NO production in fungus-infected cells, and these mechanisms contribute to the enhanced fungal killing observed in the absence of JNK1. (f) l-NAME (100 mg per kg body weight) or PBS (Ctr) was administered intraperitoneally daily to JNK1 KO mice infected with 2 × 10 5 CFU of C. albicans (n = 8 mice for each group). Survival of the mice was monitored and is plotted. In a, the multiple t-test was performed; in c, the two-tailed unpaired t-test was performed; in d-f, the log-rank test was performed. **P < 0.01, ***P < 0.001. In a,c, data are shown as means ± s.e.m. . 24 h after transfection, cells were treated with phorbol 12-myristate 13-acetate (PMA; 200 ng/ml) and ionomycin (500 ng/ml) for another 6 h. The NFAT inhibitor 11R-VIVIT (10 µM) was added 20 min before stimulation with PMA and ionomycin. Luciferase assays were performed, and luciferase activity was normalized to R-Luc activity. In f-h, data are representative of two independent experiments. In b,d,e, the multiple t-test was performed; in f-h, the two-tailed unpaired t-test was performed. n.s., P > 0.05; *P < 0.05, **P < 0.01, ***P < 0.001. In b-h, data are shown as means ± s.e.m. To confirm the functions of CD23 and NO in vivo, we collected kidney tissues from C. albicans-infected mice and found that the mRNA levels of Nos2 and Fcer2a were significantly higher in JNK1 KO mice than in WT mice ( Fig. 3a and Supplementary Fig. 6a ). CD23 protein levels in the infected kidney were also higher in JNK1 KO mice (Fig. 3b) , and p30A treatment could efficiently inhibit CD23 expression in mice (Supplementary Fig. 6b ). To evaluate whether CD23 is responsible for the protection against fungal infection found in JNK1 KO mice, we used both mice treated with CD23 blocking peptide and CD23 KO mice. The fungal burden of p30A-treated JNK1 KO mice was much higher than that of mice treated with control peptide (Fig. 3c and Supplementary Fig. 6c) , which is consistent with our in vitro data. JNK1 and CD23 double-KO mice were generated by crossing CD23 KO mice with JNK1 KO mice, and the mice generated were infected with C. albicans. In accordance with the data for the p30A blocking peptide, the increase in the survival rate of JNK1 single-KO mice in comparison to WT mice was diminished in JNK1 and CD23 double-KO mice ( Fig. 3d and Supplementary Fig. 6d) . Interestingly, JNK1 and CD23 double-KO mice died faster than WT and CD23 single-KO mice for unknown reasons. As iNOS expression was elevated in response to fungal infection in JNK1 KO mice, we treated C. albicans-infected JNK1 KO mice with the NOS1-specific inhibitor spermidine and the iNOS (NOS2)-specific inhibitor SMT (Supplementary Fig. 6e ). We found that SMT, but not spermidine, significantly reduced the survival rate of these mice as compared with control treatment (Fig. 3e) . This iNOS-specific effect was confirmed using another inhibitor, l-NAME, which also reduced the survival rate of infected JNK1 KO mice (Fig. 3f) . These data indicate that induction of CD23 expression and CD23-dependent elevation of NO levels are responsible for the enhanced antifungal immune response found in JNK1 KO mice.
Monocytes/macrophages, DCs and neutrophils are all reported to be important components of the host antifungal immune response 18, 19, 35 . We examined which types of cells showed increased expression of CD23 and iNOS in C. albicans-infected mice and found that expression of Fcer2a and Nos2 was significantly induced in BDMCs and DCs, but not in neutrophils, from JNK1 KO mice after fungal infection (Supplementary Fig. 7a ). Neutrophil number was lower in JNK1 KO mice after fungal infection ( Supplementary  Fig. 7b,c) , which may have been caused by the lower fungal burden and reduced inflammatory response present 7 d after initial infection. Notably, peritoneal macrophages from CD23 KO mice expressed less Nos2 mRNA than corresponding cells from heterozygous littermates (Supplementary Fig. 7d ). The fungal load was much higher in the kidneys of CD23 KO mice than it was in WT mice after C. albicans infection (Supplementary Fig. 7e) . ROS production and phagocytosis are also important processes in antifungal responses 19, 36, 37 , and NO can interact with ROS and form peroxynitrite to efficiently kill fungi 26, 38 . We found that JNK1-deficient BMDMs produced higher amounts of ROS than WT cells upon C. albicans infection (Supplementary Fig. 8a ), but the ability of these cells to perform phagocytosis was comparable (Supplementary Fig. 8b,c) .
JNK1 negatively regulates CD23 expression through dectin-1-induced NFAT activation
We next investigated how JNK1 deficiency results in upregulated CD23 expression following fungal infection. It has been shown that JNK1-deficient T cells exhibit elevated NFAT activation upon stimulation 39 , and NFAT binding to the CD23 promoter regulates expression of this gene 40, 41 . Interestingly, stimulation with C. albicans can also trigger NFAT activation in macrophages and DCs 42, 43 . To determine the molecular mechanism by which CD23 expression is upregulated /6 mice (n = 8 mice for each group) were intravenously infected with 3 × 10 5 CFU of C. albicans and beginning 24 h later were injected intraperitoneally with 10 mg per kg body weight per day SP600125 for four consecutive days. Survival of these mice was monitored and is plotted. In a,e,g, the log-rank (Mantel-Cox) test was performed; in b,c, the two-tailed unpaired t-test was performed; in f, the multiple t-test was performed. **P < 0.01, ***P < 0.001. In b,c,f, data are shown as means ± s.e.m.
following fungal infection, BMDMs were stimulated with C. albicans and NFAT activation was examined. More NFATc1 translocated to the nucleus in JNK1 KO cells than in WT cells upon stimulation with C. albicans, although nuclear translocation of the p65 NF-κB subunit was comparable (Fig. 4a-c) . Notably, JNK phosphorylation and NFAT activation were dependent on dectin-1, as dectin-1 KO BMDMs showed significantly reduced NFAT activation and JNK phosphorylation upon stimulation with intact C. albicans or the dectin-1 ligand, zymosan, whereas p65 translocation was not affected by dectin-1 loss upon stimulation with either α-mannan or zymosan This results in production of a large quantity of NO, which kills C. albicans. However, in WT cells, the basal level of CD23 is expressed following infection.
In a-c, the multiple t-test was performed. *P < 0.05, **P < 0.01, ***P < 0.001. In a-c, data are shown as means ± s.e.m.
a r t i c l e s 3 4 4 VOLUME 23 | NUMBER 3 | MARCH 2017 nature medicine (Fig. 4d,e and Supplementary Fig. 9a-d) . This result is consistent with the previous finding that dectin-1 stimulation by C. albicans or zymosan triggers NFAT activation in macrophages 42 .
To further determine whether CD23 induction is through an NFAT-dependent mechanism, we used 11R-VIVIT to inhibit NFAT activation and then examined the expression of CD23 in BMDMs following fungal infection. We found that CD23 expression in JNK1 KO cells was significantly reduced following stimulation with C. albicans and treatment with 11R-VIVIT in comparison to control treatment (Fig. 4f) . However, TPCA-1, which inhibits NF-κB activation through IκB kinase (IKK), hardly influenced CD23 induction. Since two putative NFAT-binding sites were found in the Fcer2a promoter (at −1,368 and −714 bp with respect to the transcription start site), we performed ChIP assays and found high-level binding of NFATc1 to the CD23 gene promoter in JNK1 KO cells following stimulation with C. albicans (Fig. 4g) . To determine whether the elevated nuclear translocation of NFATc1 dictates transcription of the Fcer2a gene, we cloned the genomic promoter (approximately 1,500 bp) of Fcer2a and performed luciferase reporter assays. We examined luciferase reporter activity and found that CD23 activation could be substantially induced when both potential NFAT-binding sites were present; adding the NFAT inhibitor 11R-VIVIT completely diminished this activation (Fig. 4h, −1,500) . Deletion of the NFAT site at −1,368 bp severely impaired CD23 promoter activation, but additional deletion of the NFAT site at −714 bp did not further reduce promoter activity (Fig. 4h, −750 and −480). These data indicate that NFATc1 regulates CD23 expression by directly binding to the site at −1,368 bp in the CD23 promoter.
JNK inhibitors promote antifungal immune responses in vivo
and in vitro SP600125 is one of the most extensively used ATP-competitive JNK inhibitors, and several studies using SP600125 have demonstrated its potential for therapeutic intervention through direct inhibition of JNK 24, 25, 44 . To investigate whether JNK inhibitors can efficiently boost the antifungal innate immune response, WT mice were infected with C. albicans and then treated with two different doses of SP600125. Administration of both doses of SP600125 increased the survival rate in comparison with control mice (Fig. 5a) . Treatment with JNK inhibitor SP600125 also significantly reduced the fungal burden (Fig. 5b) and increased Nos2 and Fcer2a (CD23) expression in the kidneys of infected mice (Fig. 5c,d) . Moreover, SP600125 specifically inhibited JNK activation and had no additional effect on phosphorylation of other MAP kinases (p38 and ERK) (Supplementary Fig. 10a,b) . To confirm the antifungal effect of the JNK inhibitor in vitro, BMDMs were pretreated with SP600125 and then stimulated with C. albicans. Cell surface staining showed higher induction of CD23 expression upon JNK inhibition than with control treatment (Supplementary  Fig. 10c) . Consistently, SP600125-treated WT BMDMs produced more NO than control-treated cells ( Supplementary Fig. 10d) ; these cells also killed fungi more efficiently than cells treated with the control, as shown by a reduced number of live fungal colonies formed within the same time period (Supplementary Fig. 10e) .
To further confirm the antifungal effect of JNK inhibition in vivo, we used another JNK inhibitor, JNK-IN-8 (ref. 45) , which specifically blocks JNK activation (Supplementary Fig. 10a,b) , to treat mice infected with the clinical C. albicans strain sc5314. Strikingly, JNK-IN-8 exhibited a greater protective effect in fungal infection than SP600125 (Fig. 5e ). These results demonstrate that JNK inhibitors can promote antifungal immune responses both in vivo and in vitro.
JNK1 is a potential therapeutic target in fungal infection
To investigate whether JNK inhibitors have a therapeutic benefit in fungal infection, we infected WT mice with C. albicans by intravenous injection and then injected these mice with JNK-IN-8 via the tail vein 24 h later. We found significantly higher fungal burden in the kidneys of solvent-treated mice than in those of mice treated with the JNK inhibitor (Fig. 5f) . To further confirm the therapeutic effect of JNK inhibitors, we first intravenously infected WT mice with C. albicans and, beginning 24 h later, treated the mice intraperitoneally with SP600125 or solvent control daily for four continuous days and monitored the mortality of these mice. We found that most of the control mice died within 10 d of infection, but mice treated with the JNK inhibitor were significantly more resistant to infection (Fig. 5g) .
To test the relevance of our results in mice to humans, we infected the human monocytic cell line THP-1 and human PBMC-derived monocytes with C. albicans. Both THP-1 and primary human cells treated with JNK inhibitor showed significant upregulation of CD23 and iNOS at the mRNA level (Fig. 6a,b) and killed fungi more efficiently in vitro, as shown by fewer live fungal colonies formed within the same time period (Fig. 6c) . Thus, we conclude that JNK1 deficiency leads to upregulation of the CLR CD23 through dectin-1-dependent NFAT hyperactivation and that this elevated level of CD23 induces cells to produce more NO through direct recognition of fungal cell wall components, thereby leading to efficient elimination of the fungal infection (Fig. 6d) . Therefore, JNK inhibition enhances antifungal immunity and may serve as a potential therapeutic strategy to protect from lethal C. albicans sepsis in the clinic.
DISCUSSION
In this study, we have shown that JNK1 functions as a negative regulator in innate immune responses against fungal infection. We found that JNK1-deficient mice are more resistant to fungal infection than WT mice and that JNK1 deficiency in myeloid cells is vital for this phenotype. CD23, a novel CLR, is significantly induced in the absence of JNK1 following fungal infection and plays a critical role in antifungal innate immunity. The greater induction of CD23 in JNK1 KO cells is dependent on increased activation of NFATc1, which binds to the CD23 promoter and induces CD23 expression in macrophages. The upregulated CD23 in turn induces a much higher level of production for NO, which kills C. albicans. Notably, JNK inhibitors show a potent antifungal effect both in vitro and in vivo through CD23 upregulation and induction of NO. Together, these findings suggest that JNK1 negatively regulates the innate immune response against C. albicans infection and that inhibition of JNK1 activation can enhance innate immunity against fungal infection.
JNK is involved in many physiological and pathological processes. The mechanisms by which JNK regulates T cell immune responses and T helper cell differentiation have been well studied using mice deficient for JNK1 or JNK2 (ref. 20) . The role of JNK in survival signaling, cell death, cancer development and diabetes is well established 21, 24, 25, 46 . Despite JNK being activated by a wide range of biological stimuli, including growth factors, cellular or oxidative stress, inflammatory cytokines and pathogens, the functional role of JNK in innate immunity, especially in responses to pathogens, has not been characterized. We show that JNK1 functions as a negative regulator of the host response to infection by the fungal pathogen C. albicans. Notably, our findings suggest potential utility for JNK inhibitors as a novel antifungal therapeutic approach.
Monocytes, which include macrophages, DCs and neutrophils, have been reported to play important roles in antifungal immune responses. During fungal infection, macrophages have a marked impact on the inflammatory environment by influencing expression of iNOS, proinflammatory cytokines and chemokines 47 . DCs can kill fungi directly or present fungal components to organ-draining lymph nodes to prime CD4 T cells 47 . When they encounter infectious particles, neutrophils initiate an antimicrobial killing program that includes phagocytosis and production of various toxic agents, including ROS 48 . Our studies find that CD23-dependent iNOS expression in JNK1 KO mice after fungal infection is significantly elevated in macrophages and DCs, but not in neutrophils. Interestingly, the number of neutrophils decreases in JNK1 KO mice upon infection, which may be owing to the lower fungal burden and reduced inflammatory responses in the host 7 d after initial infection. These data highlight the importance of NO produced by macrophages in antifungal immunity. However, the role of CD23 in host defense and its regulation of iNOS expression remain to be further investigated.
There is increasing evidence indicating that CLRs recognize microbial surface components and induce host antimicrobial innate immune responses. Several CLRs that sense both fungal and mycobacterial infections have recently been characterized. For example, dectin-1 recognizes C. albicans yeast cells by binding to surface β-glucans, whereas dectin-2 forms a heterodimer with dectin-3 to sense the hyphal form through α-mannan. However, the function of other CLR family members needs to be characterized. In our study, we report that CD23, a novel CLR that is well known for its function as a low-affinity receptor for IgE, plays an unexpected role in antifungal innate immune responses through recognition of the surface components of fungal pathogens. We have found that CD23 is an inducible CLR and can recognize the fungal surface components α-mannan and β-glucan, which regulate antifungal innate immunity. In accordance with the role of CD23 as a novel pattern recognition receptor involved in antifungal innate immune responses, we have found that modulation of CD23 by either peptide inhibitors or genetic deletion of the gene encoding CD23 has strong effects on antifungal innate immunity. Our data also indicate that CD23 regulates Nos2 expression, with this activity likely contributing to its role in antifungal innate immunity. Together, these results suggest that CD23 has other functions besides its well-known role as a low-affinity receptor for IgE.
In summary, our findings shed new light on the function of JNK1 as a negative regulator of the immune response during fungal infection and may have far-reaching and translationally relevant implications for developing novel approaches to fight fungal infection with JNK inhibitors.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
